China Medical System Holdings Limited reported no changes to its authorized share capital in February 2026. The corporation’s authorized share capital remained at 20.00 billion ordinary shares with a par value of USD 0.005 per share, totaling USD 100.00 million.
The total number of issued shares stood at 2.44 billion shares, unchanged from the previous month. The company confirmed compliance with the public float requirement of 25% for listed shares, with no adjustments to share options, warrants, or convertibles during the reporting period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments